Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3685829017 | Telavancin hydrochloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3685830010 | Telavancin hydrochloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1230391000172119 | chlorhydrate de télavancine | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1142691000172112 | telavancinehydrochloride | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Telavancin hydrochloride (substance) | Is a | Glycopeptide antibiotic | true | Inferred relationship | Some | ||
| Telavancin hydrochloride (substance) | Is modification of (attribute) | Telavancin (substance) | true | Inferred relationship | Some | ||
| Telavancin hydrochloride (substance) | Has disposition (attribute) | Antibacterial (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Telavancin (as telavancin hydrochloride) 250 mg powder for solution for injection vial | Has precise active ingredient | True | Telavancin hydrochloride (substance) | Inferred relationship | Some | 1 |
| Product containing precisely telavancin (as telavancin hydrochloride) 750 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | True | Telavancin hydrochloride (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR